710 related articles for article (PubMed ID: 15199110)
1. Ductal carcinoma in situ, complexities and challenges.
Leonard GD; Swain SM
J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Virnig BA; Tuttle TM; Shamliyan T; Kane RL
J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
Punglia RS; Schnitt SJ; Weeks JC
J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
Allred DC; Anderson SJ; Paik S; Wickerham DL; Nagtegaal ID; Swain SM; Mamounas EP; Julian TB; Geyer CE; Costantino JP; Land SR; Wolmark N
J Clin Oncol; 2012 Apr; 30(12):1268-73. PubMed ID: 22393101
[TBL] [Abstract][Full Text] [Related]
5. Current controversies in the treatment of ductal carcinoma in situ of the breast.
Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
[TBL] [Abstract][Full Text] [Related]
8. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
9. Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective.
Newman LA
J Natl Cancer Inst Monogr; 2010; 2010(41):152-7. PubMed ID: 20956822
[TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.
Cunnick GH; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):237-8. PubMed ID: 15633483
[TBL] [Abstract][Full Text] [Related]
12. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast.
Solin LJ
J Natl Cancer Inst Monogr; 2010; 2010(41):187-92. PubMed ID: 20956827
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen Initiation After Ductal Carcinoma In Situ.
Nichols HB; Bowles EJ; Islam J; Madziwa L; Stürmer T; Tran DT; Buist DS
Oncologist; 2016 Feb; 21(2):134-40. PubMed ID: 26768485
[TBL] [Abstract][Full Text] [Related]
14. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.
Kane RL; Virnig BA; Shamliyan T; Wang SY; Tuttle TM; Wilt TJ
J Natl Cancer Inst Monogr; 2010; 2010(41):130-3. PubMed ID: 20956816
[TBL] [Abstract][Full Text] [Related]
15. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
16. Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.
Guerrieri-Gonzaga A; Sestak I; Lazzeroni M; Serrano D; Rotmensz N; Cazzaniga M; Varricchio C; Pruneri G; Leonardi MC; Orecchia R; Galimberti V; Bonanni B; DeCensi A
Int J Cancer; 2016 Nov; 139(9):2127-34. PubMed ID: 27381855
[TBL] [Abstract][Full Text] [Related]
17. Trends in the treatment of ductal carcinoma in situ of the breast.
Baxter NN; Virnig BA; Durham SB; Tuttle TM
J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
[TBL] [Abstract][Full Text] [Related]
18. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.
Soeteman DI; Stout NK; Ozanne EM; Greenberg C; Hassett MJ; Schrag D; Punglia RS
J Natl Cancer Inst; 2013 Jun; 105(11):774-81. PubMed ID: 23644480
[TBL] [Abstract][Full Text] [Related]
19. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
Mitchell KB; Kuerer H
Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
[TBL] [Abstract][Full Text] [Related]
20. The impact of systemic therapy following ductal carcinoma in situ.
Eng-Wong J; Costantino JP; Swain SM
J Natl Cancer Inst Monogr; 2010; 2010(41):200-3. PubMed ID: 20956830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
